Thus, RUNX1 needs to be taken into consideration as a recombinase cofactor for a better understanding of molecular mechanisms leading to physiological (e.g. TCRβ, TCRδ) and aberrant (e.g. ETV6-RUNX1 ALL) deletions. Here, ETV6 is linked to acute lymphoblastic leukemia.